Summary & Overview
HCPCS Q4232: Corplex, dermal substitute per square centimeter
HCPCS Level II code Q4232 identifies Corplex billed per square centimeter as an add-on supply used in wound and soft-tissue management. The code is reported in addition to a primary procedure when Corplex is applied to a wound bed or surgical site and is intended to capture product usage on a per-area basis. Nationally, accurate reporting of add-on product codes like Q4232 supports appropriate payment for advanced wound care materials and aligns clinical documentation with claims processing.
Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise summary of clinical context for Corplex use, typical sites of service where the product is applied, common modifiers and billing considerations, and notes on how the code functions as an add-on to primary procedures. The publication also outlines expected documentation elements and common claim-line practices needed to support medical necessity.
This briefing is aimed at billing managers, coding professionals, and clinical leaders who need a clear national overview of the code’s purpose, payer landscape, and the types of information payers typically require on claim submission. Data not available in the input for payer-specific rates, associated taxonomies, and ICD-10 pairings are noted where applicable.
Billing Code Overview
HCPCS Level II code Q4232 denotes Corplex, billed per square centimeter (add-on, list separately in addition to primary procedure). This code represents an adjunctive wound care product applied and reported in addition to a primary surgical or wound management procedure.
Service type: Topical biologic/dermal substitute application for wound management
Typical site of service: Hospital outpatient, ambulatory surgery center, and clinic-based wound care settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a full-thickness or complex soft tissue wound (for example, a chronic diabetic foot ulcer, traumatic skin loss, or a surgical wound with significant dermal deficit) requiring advanced dermal substitute application. The clinical workflow begins with wound assessment by a surgeon or wound care specialist, debridement of nonviable tissue, hemostasis, and irrigation. After achieving a clean wound bed, the provider measures the defect in square centimeters and applies the dermal matrix product Corplex as an adjunct to primary wound closure or grafting. The product is billed as an add-on per square centimeter (Q4232) in addition to the primary procedure (for example, grafting or complex wound closure). Typical sites of service include outpatient surgical centers, hospital outpatient departments, and inpatient operating rooms when used during definitive surgical management. The patient is commonly followed in a clinic or wound center for dressing changes, monitoring for integration of the dermal matrix, and for any staged procedures such as delayed split-thickness skin grafting if indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — typical service | Use when no specific circumstance modifier applies and the service is provided as described. |